Dietary corn oil promotes colon cancer by inhibiting mitochondria-dependent apoptosis in azoxymethane-treated rats

Experimental Biology and Medicine

Volumn 229, Issue 10, 2004, Pages 1017-1025

  Wu, Bin ^a   Iwakiri, Ryuichi ^a   Ootani, Akifumi ^a   Tsunada, Seiji ^a   Fujise, Takehiro ^a   Sakata, Yasuhisa ^a   Sakata, Hiroyuki ^a   Toda, Shuji ^a   Fujimoto, Kazuma ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Aberrant crypt foci; Adenoma; Bcl 2 family protein; Mitochondria; Polyunsaturated fatty acid

Indexed keywords

AZOXYMETHANE; CORN OIL; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; COLON ADENOMA; COLON CANCER; CONTROLLED STUDY; DIET SUPPLEMENTATION; MALE; MITOCHONDRION; NONHUMAN; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALIA; ZEA MAYS;

EID: 7244227674     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422901005     Document Type: Article

References (46)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 53:5-26, 2003.
2. Tavani A, Pelucchi C, Parpinel M, Negri E, Franceschi S, Levi F, La Vecchia C. n-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland. Int J Cancer 105:113-116, 2003.
3. Reddy BS. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev 9:239-247, 2000.
4. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61:1927-1933, 2001.
5. Dai W, Liu T, Wang Q, Rao CV, Reddy BS. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. Int J Oncol 20:121-126, 2002.
6. 2 synthesis. Gut 46:191-199, 2000.
7. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37:147-151, 1987.
8. Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15:1049-1054, 1994.
9. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 124:361-367, 2003.
10. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, Stellato TA. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 51:1564-1567, 1991.
11. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H, Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339:1277-1284, 1998.
12. Steller H. Mechanisms and genes of cellular suicide. Science 267:1445-1449, 1995.
13. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462, 1995.
14. Arai T, Kida Y, Harmon BV, Gobe GC. Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br J Cancer 74:406-412, 1996.
15. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102:849-862, 2000.
16. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G, Dausman J, Lee P, Wilson C, Lander E, Jaenisch R. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27:31-39, 2001.
17. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404:42-49, 2000.
18. Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F, Arias C, Silva A, Tortolero M, Pintor-Toro JA. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 32:306-311, 2002.
19. Ding HF, Lin YL, McGill G, Juo P, Zhu H, Blenis J, Yuan J, Fisher DE. Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J Biol Chem 275:38905-38911, 2000.
20. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053-1058, 2000.
21. Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM. Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 20:240-251, 2001.
22. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153-164, 2002.
23. Woods DB, Vousden KH. Regulation of p53 function. Exp Cell Res 264:56-66, 2001.
24. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11:577-590, 2003.
25. Brenner C, Kroemer G. Apoptosis. Mitochondria - the death signal integrators. Science 289:1150-1151, 2000.
26. Hong MY, Chapkin RS, Morris JS, Wang N, Carroll RJ, Turner ND, Chang WC, Davidson LA, Lupton JR. Anatomical site-specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model. Carcinogenesis 22:1831-1835, 2001.
27. Zalatnai A, Lapis K, Szende B, Raso E, Telekes A, Resetar A, Hidvegi M. Wheat germ extract inhibits experimental colon carcinogenesis in F-344 rats. Carcinogenesis 22:1649-1652, 2001.
28. Nozawa H, Yoshida A, Tajima O, Katayama M, Sonobe H, Wakabayashi K, Kondo K. Intake of beer inhibits azoxymethane-induced colonic carcinogenesis in male Fischer 344 rats. Int J Cancer 108:404-411, 2004.
29. Wu B, Iwakiri R, Tsunada S, Utsumi H, Kojima M, Fujise T, Ootani A, Fujimoto K. iNOS enhances rat intestinal apoptosis after ischemia-reperfusion. Free Radic Biol Med 33:649-658, 2002.
30. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132, 1997.
31. Wu D, Wallen HD, Nuñez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275:1126-1129, 1997.
32. Ou XW, Wang H, De Plaen IG, Rozenfeld RA, Hsueh W. Neuronal nitric oxide synthase (NOS) regulates the expression of inducible NOS in rat small intestine via modulation of nuclear factor kappa B. FASEB J 15:439-446, 2001.
33. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973-2983, 1998.
34. Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95:5-8, 1998.
35. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824-1827, 2000.
36. Sharpless NE, DePinho RA. p53: good cop/bad cop. Cell 110:9-12, 2002.
37. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1:45-49, 1992.
38. Nikolaev AY, Li M, Puskas N, Qin J, Gu W. Parc: a cytoplasmic anchor for p53. Cell 112:29-40, 2003.
39. Seo YW, Shin JN, Ko KH, Cha JH, Park JY, Lee BR, Yun CW, Kim YM, Seol DW, Kim DW, Yin XM, Kim TH. The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J Biol Chem 278:48292-48299, 2003.
40. Matsuda K, Yoshida K, Taya Y, Nakamura K, Nakamura Y, Arakawa H. p53 AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res 62:2883-2889, 2002.
41. L sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8:705-711, 2001.
42. Yoshida Y, Izumi H, Torigoe T, Ishiguchi H, Itoh H, Kang D, Kohno K. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res 63:3729-3734, 2003.
43. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136, 1997.
44. Wu B, Iwakiri R, Ootani A, Fujise T, Tsunada S, Fujimoto K. Platelet-activating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion. FASEB J 17:1156-1158, 2003.
45. Wu B, Ootani A, Iwakiri R, Fujise T, Tsunada S, Toda S, Fujimoto K. Ischemic preconditioning attenuates ischemia/reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine. Am J Physiol 286:G580-G587, 2004.
46. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489, 1997.